Rare Tumors in Children: Trends in Diagnosis, Treatment and Prevention (Volume II)

Dear Colleagues,

We are excited to invite you to contribute to this Special Issue, which is the second edition of “Rare Tumors in Children: Trends in Diagnosis, Treatment and Prevention” (https://0-www-mdpi-com.brum.beds.ac.uk/journal/cancers/special_issues/Rare_Tumors).

Rare cancers constitute a heterogeneous family of pathologies that can affect almost any part of the body. Rare cancers are associated with a series of challenges and issues related to their status as rare diseases. The difficulties involve both the patient’s diagnostic and therapeutic pathway and the impact on the efficiency of national healthcare systems.

Regarding rare diseases, the possibility of conducting clinical studies on both diagnostic and therapeutic aspects is limited. Therefore, national and international collaborations have been active for many years in order to conduct meaningful clinical studies. These scientific and clinical networks have made it possible to achieve significant results in the field of pediatric oncology. Nevertheless, not all children and adolescents with tumors have benefited from these efforts. Rare cancers are therefore ‘orphan’ diseases characterized by limited clinical experience, a lack of shared guidelines and little investment in research. However, in recent years, these rare diseases have attracted more attention and a number of collaborative groups on rare cancers have been established, with the aim of fostering the circulation and exchange of useful information in both the diagnostic and therapeutic phases.

These observations confirm that young patients with rare tumors need specific diagnostic and therapeutic approaches and represent a real challenge for the scientific world of pediatric oncology.

This Special Issue will highlight the current state of the art and trends in the diagnosis, treatment and prevention of rare tumors in children.

In this Special Issue, original research articles and reviews are welcome.

I look forward to receiving your contributions.

Dr. Antonio Ruggiero
Dr. Stefano Mastrangelo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• pediatric oncology
• pediatric drugs
• clinical pharmacology